CicloMed LLC
🇺🇸United States
- Country
- 🇺🇸United States
- Ownership
- Holding
- Established
- 2015-01-01
- Employees
- 1
- Market Cap
- -
- Website
- http://www.ciclomed.com
Study of Fosciclopirox in Patients With Relapsed/Refractory Acute Myeloid Leukemia
Phase 1
Terminated
- Conditions
- Recurrent Acute Myeloid LeukemiaRefractory Acute Myeloid Leukemia
- Interventions
- First Posted Date
- 2021-07-09
- Last Posted Date
- 2024-02-12
- Lead Sponsor
- CicloMed LLC
- Target Recruit Count
- 18
- Registration Number
- NCT04956042
- Locations
- 🇺🇸
John Hopkins School of Medicine, Baltimore, Maryland, United States
🇺🇸University of Kansas Medical Center, Kansas City, Kansas, United States
Safety, Dose Tolerance, Pharmacokinetics, and Pharmacodynamics Study of CPX-POM in Patients With Advanced Solid Tumors
- First Posted Date
- 2020-10-29
- Last Posted Date
- 2025-03-03
- Lead Sponsor
- CicloMed LLC
- Target Recruit Count
- 9
- Registration Number
- NCT04608045
- Locations
- 🇺🇸
University of Kansas Medical Center, Kansas City, Kansas, United States
Safety, Dose Tolerance, Pharmacokinetics, Pharmacodynamics of CPX-POM in Patients With Newly Diagnosed or Recurrent Bladder Tumors
- First Posted Date
- 2020-08-25
- Last Posted Date
- 2024-06-18
- Lead Sponsor
- CicloMed LLC
- Target Recruit Count
- 12
- Registration Number
- NCT04525131
- Locations
- 🇺🇸
University of Kansas Medical Center, Kansas City, Kansas, United States
Safety, Dose Tolerance, Pharmacokinetics, and Pharmacodynamics Study of CPX-POM in Patients With Advanced Solid Tumors
Phase 1
Completed
- Conditions
- Advanced Solid Tumors
- Interventions
- Drug: CPX-POM - 600 mg/m^2Drug: CPX-POM - 30 mg/m^2Drug: CPX-POM - 360 mg/m^2Drug: CPX-POM - 1200 mg/m^2Drug: CPX-POM - 240 mg/m^2Drug: CPX-POM - 60 mg/m^2Drug: CPX-POM - 120 mg/m^2Drug: CPX-POM - 900 mg/m^2
- First Posted Date
- 2017-11-21
- Last Posted Date
- 2021-12-03
- Lead Sponsor
- CicloMed LLC
- Target Recruit Count
- 19
- Registration Number
- NCT03348514
- Locations
- 🇺🇸
Sarah Cannon Research Institute, Denver, Colorado, United States
🇺🇸Florida Cancer Specialists & Research Institute, Sarasota, Florida, United States
🇺🇸Stephenson Cancer Center, Oklahoma City, Oklahoma, United States
© Copyright 2025. All Rights Reserved by MedPath